• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Leqembi® (lecanemab)

Leqembi® (lecanemab) launched in China

BioArctic AB's partner Eisai announced  that Leqembi® generic name: lecanemab has been launched in China. Leqembi received approval in January 2024 as a treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD dementia. China is the third country to launch Leqembi following the United States and Japan.

Read more →